Full text is available at the source.
The regulation of ginsenoside Rg1 upon aging of bone marrow stromal cell contribute to delaying senescence of bone marrow mononuclear cells (BMNCs)
Ginsenoside Rg1 helps delay aging in bone marrow cells by affecting bone marrow support cells
AI simplified
Abstract
Rg1 significantly decreased the percentage of positive cell SA-Gal staining in bone marrow stromal cells (BMSCs) from an aging rat model.
- Rg1 treatment reduced the effects of aging on BMSCs by lowering the rate of senescence-associated β-galactosidase (SA-Gal) positive cells.
- Increased proliferative ability of BMSCs was observed after Rg1 treatment, indicating enhanced cell growth.
- Co-culturing bone marrow nucleated cells (BMNCs) with Rg1-treated BMSCs led to a decreased apoptosis rate and improved mixed colony formation.
- In BMNCs, Rg1 treatment resulted in reduced SA-Gal positive cell staining and enhanced colony-forming unit capacity.
- Rg1 may restore hematopoietic capacity in BMNCs by counteracting aging effects through multiple pathways.
AI simplified